JNJ
Johnson & JohnsonNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$564.11B
P/E Ratio
27.19
EPS
$8.62
Beta
0.26
52W High
$251.71
52W Low
$146.24
50-Day MA
$233.36
200-Day MA
$210.74
Dividend Yield
2.24%
Profit Margin
21.80%
Forward P/E
20.24
PEG Ratio
3.05
About Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Fundamentals
| Revenue (TTM) | $96.36B |
| Gross Profit (TTM) | $65.56B |
| EBITDA | $34.33B |
| Operating Margin | 27.40% |
| Return on Equity | 26.40% |
| Return on Assets | 8.42% |
| Revenue/Share (TTM) | $40.02 |
| Book Value | $33.73 |
| Price-to-Book | 6.95 |
| Price-to-Sales (TTM) | 5.85 |
| EV/Revenue | 6.2 |
| EV/EBITDA | 17.71 |
| Quarterly Earnings Growth (YoY) | -52.90% |
| Quarterly Revenue Growth (YoY) | 9.90% |
| Shares Outstanding | $2.41B |
| Float | $2.40B |
| % Insiders | 0.05% |
| % Institutions | 77.01% |
Historical Volatility
HV 10-Day
18.72%
HV 20-Day
17.64%
HV 30-Day
18.67%
HV 60-Day
17.08%
HV Rank
80.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($252.96 target)
5
Strong Buy9
Buy10
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/23/2026